The transforming growth factor-Beta signaling pathway involvement in cardiovascular lesions in

S Yano1, C Li, Z Pavlova

  • 1Genetics Division, Department of Pediatrics, LAC + USC Medical Center, University of Southern California, General Laboratory Building Rm 1 G-24, 1801 Marengo Street, Los Angeles, 90033, CA, USA, syano@usc.edu.

JIMD Reports
|February 23, 2013
PubMed

Insights

Mucopolysaccharidoses (MPS) cause cardiovascular issues due to enzyme deficiencies. In MPS-I, hyperactive transforming growth factor-beta (TGF-β) signals contribute to heart and blood vessel damage, suggesting new therapeutic targets.

Area of Science:

  • Genetics and Molecular Biology
  • Cardiovascular Medicine
  • Lysosomal Storage Diseases

Background:

  • Mucopolysaccharidoses (MPS) are genetic disorders impairing glycosaminoglycan metabolism.
  • Cardiovascular manifestations are common in MPS, particularly MPS-I, II, and VI.
  • Existing enzyme replacement therapy (ERT) has limited efficacy for cardiovascular complications in MPS-I.

Purpose of the Study:

  • To investigate the underlying mechanisms of cardiovascular pathology in Mucopolysaccharidosis type I (MPS-I).
  • To explore the role of transforming growth factor-beta (TGF-β) signaling in MPS-I cardiovascular disease.
  • To identify potential new therapeutic strategies for MPS-associated cardiac conditions.

Main Methods:

  • Immunohistopathological analysis of cardiac tissue from an MPS-I patient.
  • Assessment of phosphorylated Smad2 staining to evaluate TGF-β signaling activity.
  • Correlation of TGF-β pathway activation with observed cardiovascular lesions.

Main Results:

  • Hyperactive TGF-β signaling was identified in the intimal layer, endocardium, and myocardial cells.
  • Evidence of myointimal proliferation and coronary artery stenosis linked to TGF-β hyperactivity.
  • Cardiovascular lesions, including hypertrophic cardiomyopathy and thickened valves, showed signs of TGF-β pathway involvement.

Conclusions:

  • Hyperactive TGF-β signaling is implicated in the pathogenesis of cardiovascular lesions in MPS-I.
  • These findings suggest TGF-β pathway modulation as a potential therapeutic avenue for MPS-I cardiovascular disease.
  • Further research is needed to explore TGF-β inhibitors, like losartan, for treating MPS-related cardiovascular complications.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Proteoglycans01:05

Proteoglycans

Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...